Cure My Disease

Don't miss your cure!

 Log in / Sign up

Multiple myeloma patients get continued access to promising drug

NCT ID NCT02719613

Completed Disease control Sponsor: Bristol-Myers Squibb Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study offers continued treatment with elotuzumab (plus dexamethasone) to 67 multiple myeloma patients who were already benefiting from it in earlier trials. The main goal is to keep providing the drug and track how long patients stay on treatment. Researchers will also monitor any new or serious side effects. This is not a test of whether the drug works, but a way to ensure ongoing access for those who need it.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Elotuzumab (with dexamethasone)

What this could lead to

If successful, this study allows patients to keep receiving a treatment that may help control their multiple myeloma without interruption.

What could go wrong

This is an extension study, not a new test of effectiveness. It only includes patients already benefiting, so results may not apply to everyone. Side effects from long-term use remain possible.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

plasma cell myeloma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MULTIPLE MYELOMA

Contacts and locations

Locations

  • Local Institution - 0001

    Bethlehem, Pennsylvania, 18015, United States

  • Local Institution - 0002

    Boston, Massachusetts, 02215, United States

  • Local Institution - 0003

    Indianapolis, Indiana, 46260, United States

  • Local Institution - 0004

    New York, New York, 10029, United States

  • Local Institution - 0008

    St Louis, Missouri, 63110, United States

  • Local Institution - 0009

    Atlanta, Georgia, 30322, United States

  • Local Institution - 0010

    Halifax, B3H 2Y9, Canada

  • Local Institution - 0011

    Toronto, Ontario, M5G 2M9, Canada

  • Local Institution - 0012

    Florence, 50134, Italy

  • Local Institution - 0013

    Genova, 16132, Italy

  • Local Institution - 0014

    Torino, 10126, Italy

  • Local Institution - 0015

    Ancona, 60126, Italy

  • Local Institution - 0016

    West Hollywood, California, 90069, United States

  • Local Institution - 0017

    Bakersfield, California, 93309, United States

  • Local Institution - 0018

    Dallas, Texas, 75231, United States

  • Local Institution - 0019

    Denver, Colorado, 80218, United States

  • Local Institution - 0020

    Tucson, Arizona, 85715, United States

  • Local Institution - 0021

    Jacksonville, Florida, 32256, United States

  • Local Institution - 0022

    Fountain Valley, California, 92708, United States

  • Local Institution - 0023

    Antwerp, 2060, Belgium

  • Local Institution - 0026

    Warsaw, 02-106, Poland

  • Local Institution - 0027

    Chorzów, 41-500, Poland

  • Local Institution - 0028

    Bucharest, 030171, Romania

  • Local Institution - 0029

    Iași, 700483, Romania

  • Local Institution - 0030

    Toledo, 45004, Spain

  • Local Institution - 0031

    Cebeci Ankara, 06620, Turkey (Türkiye)

  • Local Institution - 0032

    London, EC1A 7BE, United Kingdom

  • Local Institution - 0034

    Heidelberg, Victoria, 3084, Australia

  • Local Institution - 0035

    Athens, 11528, Greece

  • Local Institution - 0036

    Budapest, 1097, Hungary

  • Local Institution - 0039

    Warsaw, 02-776, Poland

  • Local Institution - 0041

    Barcelona, 08036, Spain

  • Local Institution - 0042

    St. Petersburg, Florida, 33705, United States

  • Local Institution - 0043

    Ravenna, 48121, Italy

  • Local Institution - 0044

    Terni, 05100, Italy

  • Local Institution - 0045

    Kasama-shi, 3091793, Japan

  • Local Institution - 0046

    Aomori, Aomori, 0308553, Japan

  • Local Institution - 0047

    Shibukawa-shi, Gunma, 3770280, Japan

  • Local Institution - 0048

    Koto-ku, Tokyo, 135-8550, Japan

  • Local Institution - 0049

    Osaka, Osaka, 5300012, Japan

  • Local Institution - 0050

    Chiba, 260-8677, Japan